Rotavirus gastroenteritis in Indian children < 5 years hospitalized for diarrhoea, 2012 to 2016

In 2016, the Government of India introduced the oral rotavirus vaccine (ROTAVAC, Bharat Biotech, India) in 4 states of India as part of the Universal Immunization Programme, and expanded to 5 more states in 2017. We report four years of data on rotavirus gastroenteritis in hospitalized children

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	BMC public health 2019-01, Vol.19 (1), p.69-69, Article 69
Hauptverfasser:	Giri, Sidhartha, Nair, Nayana P, Mathew, Ann, Manohar, B, Simon, Anna, Singh, Tejinder, Suresh Kumar, S, Mathew, M A, Babji, Sudhir, Arora, Rashmi, Girish Kumar, C P, Venkatasubramanian, S, Mehendale, Sanjay, Gupte, Mohan D, Kang, Gagandeep
Format:	Artikel
Sprache:	eng
Schlagworte:	Age Biotechnology Childhood diarrhea Children Diarrhea Diarrhoea Enzyme immunoassay Enzymes Epidemiology Gastroenteritis Genotypes Genotyping Hospital patients Hospitalization Hospitals Immunization Immunoassay India Medical research Polymerase chain reaction Public health Rotavirus Rotavirus infections Statistics Studies Surveillance Vaccines Viruses
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	In 2016, the Government of India introduced the oral rotavirus vaccine (ROTAVAC, Bharat Biotech, India) in 4 states of India as part of the Universal Immunization Programme, and expanded to 5 more states in 2017. We report four years of data on rotavirus gastroenteritis in hospitalized children
ISSN:	1471-2458 1471-2458
DOI:	10.1186/s12889-019-6406-0